Nucleic Acid Standards for Biosecurity Act

The House considered H.R. 3029, the Nucleic Acid Standards for Biosecurity Act, which directs the National Institute of Standards and Technology to develop standards and best practices for screening synthetic DNA and RNA orders, so that custom-made genetic material cannot be misused to create dangerous biological agents. Brian Babin said the bill would have the government work with scientists and companies to create clear screening standards while supporting the biotech industry, and Andrea Salinas said the standards would help American biotech keep growing safely as it develops new medicines. Members spoke in support, and the bill was brought up under a suspended-rules procedure.Written by AI from the debate. Updated .

Official text (opens in a new tab)

1 statement

Andrea Salinas, OR

Democrat
“I want the House to pass this bill. American scientists use synthetic DNA and RNA to create new medicines and technologies. This bill helps the government set safety standards for this work so the industry can keep growing safely in America.”
Official Congressional Record

Madam Speaker, I yield myself the balance of my time. Madam Speaker, American biotech companies are leading a scientific revolution that is transforming our economy. In recent years, we have seen breakthroughs that have delivered promising new treatments for Alzheimer’s, new biological alternatives to pesticides, and plastic- eating bacteria, just to name a few. These innovations are making Americans healthier, driving a more sustainable economy, and supporting good jobs. However, while America leads the world in these emerging technologies, our competitors are close behind. If we want to ensure American industry stays on top, then American consumers must have confidence in the safety and reliability of our advancements. One of the key ways American companies produce these breakthroughs is by producing synthetic nucleic acids, like DNA and RNA, for use in biotech research. These are an important tool though that allows scientists to study gene function, develop novel vaccines, improve diagnostic tests, and pursue countless other life-changing discoveries. Companies like Twist Bioscience in my district are pushing the envelope to accelerate and scale-up production, which, in turn, will facilitate faster discoveries. As this field advances, particularly with the development of AI systems to design nucleic acid sequences, we need to double down on efforts to ensure the technology is used safely and responsibly. H.R. 3029, the Nucleic Acid Standards for Biosecurity Act, directs the National Institute of Standards and Technology to carry out measurement research and lead consensus-driven standards development to ensure these tools can be harnessed in a trustworthy manner. Businesses, small and large, in Oregon and across the country, will benefit from this partnership with NIST. These standards will drive sustainable growth while helping to keep this industry and the good jobs it supports right here in America. Through a commonsense partnership between government and industry, we will unlock responsible and trustworthy growth that benefits industry, workers, and consumers across the economy. Madam Speaker, in closing, I want to extend my great gratitude to Chairman Babin and Mr. McCormick for their bipartisan work. I urge my colleagues to vote ``yes’’ on H.R. 3029, and I yield back the balance of my time.

Discussion

No comments yet

See the full discussion

Comment rules

More from issue 118

  1. House of Representatives Honoring Life of Douglas Graham 4 statements
  2. House of Representatives Recognizing Larry "the Grinch" Stone 2 statements
  3. House of Representatives Commemorating 82nd Anniversary of Liberation of Guam 2 statements
  4. House of Representatives Choices for Increased Mobility Act of 2026 5 statements
  5. House of Representatives Destruction of Hazardous Imports Act 6 statements
  6. House of Representatives FDA Modernization Act 3.0 6 statements
  7. House of Representatives Reauthorizing the Kay Hagan Tick Act 6 statements
  8. House of Representatives Stem Cell Therapeutic and Research Reauthorization Act of 2025 6 statements
  9. House of Representatives Accelerating Access to Dementia and Alzheimer's Provider Training Act 6 statements
  10. House of Representatives Action for Dental Health Act 7 statements
  11. House of Representatives Programs to Prevent, Detect, and Treat Traumatic Brain Injuries 4 statements
  12. House of Representatives Early Act Reauthorization of 2025 7 statements
  13. House of Representatives Deondra Dixon Include Project Act of 2025 5 statements
  14. House of Representatives NIH Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone Act 7 statements
  15. House of Representatives Accelerating Access to Critical Therapies for Als Reauthorization Act of 2026 6 statements
  16. House of Representatives Putting Patients First by Strengthening Provider Accountability in Feca Act 6 statements
  17. House of Representatives Value over Cost Act of 2026 3 statements
  18. House of Representatives Ensuring Federal Purchasing Efficiency Act 6 statements
  19. House of Representatives Stop Secret Spending Act of 2025 6 statements
  20. House of Representatives Federal Improvement in Technology Procurement Act 4 statements
  21. House of Representatives Federal Relocation Payment Improvement Act 5 statements
  22. House of Representatives Billion Dollar Boondoggle Act 5 statements
  23. House of Representatives Expanding Whistleblower Protections for Contractors Act of 2026 3 statements
  24. House of Representatives Nucleic Acid Standards for Biosecurity Act 5 statements
  25. House of Representatives Next-Generation Geothermal Research and Development Act 7 statements
  26. House of Representatives Recognizing 100th Anniversary of Long Island Association 9 statements
  27. House of Representatives Honoring the Life and Legacy of Congressman John Lewis 4 statements
  28. Senate Cloture Motion (Executive Calendar) 2 statements
  29. Senate Order for Adjournment 17 statements